$1.43
-0.04-2.72%
Last update: Oct 14, 4:00 PM
Innate Pharma SA
IPHANASDAQ
Wall Street analyst price targets and consensus rating for Innate Pharma (IPHA).
Price Target Range — 12 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
